# Response to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic Polymorphisms

> **NCT03349320** · — · COMPLETED · sponsor: **Federal University of Minas Gerais** · enrollment: 37 (actual)

## Conditions studied

- Late Onset Alzheimer Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03349320
- **Lead sponsor:** Federal University of Minas Gerais
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2017-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03349320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03349320, "Response to Donepezil, Drug Plasma Concentration and the CYP2D6 and APOE Genetic Polymorphisms". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03349320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*